Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Stratification for VTE Prophylaxis After TKR
NCT04031859Phase 2Completed
- Sponsor
- Ministry of Health
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in venous thromboembolism (VTE), sponsored by Ministry of Health. Started Oct 2018; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04031859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031859.